New cationic polyprenyl derivative proposed as a lipofecting agent by Madeja, Zbigniew et al.
Communication
New cationic polyprenyl derivative proposed as a lipofecting agent*
Zbigniew Madeja1, Monika Rak1, Ewa Wybieralska1, Igor Różański1, 
Marek Masnyk2, Marek Chmielewski2, Robert Łysek2, Tadeusz Chojnacki3, 
Wiesław Jankowski3, Ewa Ciepichal3, Ewa Swiezewska3, Michael Tekle4 
and Gustav Dallner4
1Department of Cell Biology, Faculty of Biochemistry, Biophysics and Biotechnology, Jagiellonian University, 
Krakow, Poland; 2Institute of Organic Chemistry PAS, Warszawa, Poland; 3Institute of Biochemistry and Bio-
physics PAS, Warszawa, Poland; 4Arrhenius Laboratory, Department of Biochemistry and Biophysics, Stockholm 
University, Stockholm, Sweden
Received: 24 August, 2007; revised: 19 September, 2007; accepted: 22 September, 2007 
available on-line: 08 December, 2007
Cationic linear poly-cis-isoprenoid prepared from natural plant polyprenol in a mixture with dio-
leyl phosphatidylethanolamine was found to be an effective lipofection agent for eukaryotic cells. 
The transfecting activity is related to the poly-cis structure of the polyprenyl chain.
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INTRODUCTION
The linear polymers of isoprene residues were 
found to be lipid components of the systems of glyc-
osylation in prokaryotes and eukaryotes (Robbins et 
al, 1967; Chojnacki & Dallner, 1988), thus establishing 
this new class of lipids as specific, crucial elements 
of cellular metabolism. The discovery of this class of 
lipids documented in the nineteen sixties (Burgos et 
al., 1963; Lindgren, 1965; Stone et al., 1967) was fol-
lowed by testing their effect on membrane structure 
(Valterson et al., 1985; Janas et al., 1986) and thus 
approaching the mechanism of their coenzymatic 
functions. There were also trials to find the possible 
effect of these substances on eukaryotic cells (Ko-
rohoda et al., 1980) and the motility of cells was af-
fected even by low amounts of dolichol (α-saturated 
poly-cis-prenol). The linear isoprenoids known so far 
occur in nature as alcohols, esters with acetic acid or 
fatty acids, phosphates or pyrophosphates and also 
as diesters with sugars. The cationic form of poly-
prenols or dolichols which are most probably absent 
from living organisms and have never been the sub-
ject of interest in bioorganic chemistry may be inter-
esting substances as components of typical lipofect-
ing cocktails allowing the transfer of genetic material 
into the cells of interest. So far, only non-isoprenoid 
methylene based cationic lipids have been used in 
the lipofecting cocktails of Lipofectamine 2000 (cf. 
leaflet of Lipofectamine Reagent, 2004). 
The aim of this report is to present the case 
a lipofecting activity of heptaprenyltrimethylammo-
nium iodide in a model system of human prostate 
cancer cells.
MATERIALS AND METHODS
Heptaprenyltrimethylammonium iodide is 
one of the set of compounds of this type prepared 
by the method of Sen & Roach (1995) from natu-
rally occuring poly-cis-prenols. The biological results 
*This paper is dedicated to Professor Tadeusz Chojnacki from the Institute of Biochemistry and Biophysics, Polish Acad-
emy of Sciences in Warsaw on the occasion of the 50th anniversary of his scientific activity and 75th birthday.
Correspondence to: Zbigniew Madeja, Department of Cell Biology, Faculty of Biochemistry, Biophysics and Biotechnol-
ogy, Jagiellonian University; Gronostajowa 7, 30-378 Kraków, Poland; phone: (48) 12 664 6142; e-mail: z.madeja@uj.edu.pl
Abbreviations: DOPE, dioleyl phosphatidylethanolamine; FCS, fetal calf serum; GFP, green fluorescent protein; PBS, 
phosphate-buffered saline.
Vol. 54 No. 4/2007, 873–876
on-line at: www.actabp.pl
874            2007Z. Madeja and others
(negative) obtained on using all-trans-nonaprenylt-
rimethylammonium iodide prepared by the same 
method are also stated in this report.
The preparation of a range of these com-
pounds from naturally occurring polyprenols and 
dolichols is described elsewhere (Masnyk et al., in 
preparation) and these substances are the subject of 
a patent application (No. PL 382448).
The heptaprenyltrimethylammonium iodide 
(Fig. 1A) was prepared from poly-cis-heptaprenol 
isolated from wood of Betula verrucosa (Lindgren, 
1965) and nonaprenyltrimethylammonium iodide 
(Fig. 1B) from all-trans-nonaprenol (solanesol) iso-
lated from commercially available tobacco leaves 
(Rowland et al., 1956). Both products were found to 
be stable when checked by thin-layer chromatogra-
phy on silica gel plates (Merck) (single spots in chlo-
roform/methanol/water (65 : 25 : 4, by vol.) RF = 0.66 
in n-butanol/acetic acid/water (66 : 17 : 17, by vol.) 
RF = 0.23; in n-propanol/ammonia/water (8 : 1 : 1, by 
vol.) RF = 0.10 and in ethyl acetate/methanol/acetic 
acid (75 : 20 : 5, by vol.); RF  = 0.03; RF the same for 
both compounds after one year storage in a dry state 
under argon atmosphere). Dioleyl phosphatidyleth-
anolamine (DOPE) was from Avanti Polar Lipids 
(USA).
Lipofecting mixtures. The Lipofectamine 2000 
Reagent was from Invitrogen Corporation (USA). 
The lipofecting mixture containing our new cationic 
isoprenoids (Fig. 1) was made by making a suspen-
sion with dioleyl phosphatidylethanolamine. In the 
control experiments with Lipofectamine Reagent the 
polycationic lipid 2,3-dioleyl-N-[2(sperminecarbox-
amido)ethyl]-N,N-dimethyl-1-propanaminium trif-
luoroacetate (DOSPA) and the neutral lipid dioleyl 
phosphatidylethanolamine (Invitrogen Corporation, 
Carlsbad, CA, USA) in a 3 : 1 (w/w) were used. 
Other proportions of the ingredients were also used 
with the aim of finding optimal conditions for trans-
fection in the liposome formulation.
Cell culture. DU145 cells (human prostate 
cancer cells) were cultured in DMEM-F12 medium 
(Sigma, St. Louis, MO, USA), supplemented with 
10% heat-inactivated fetal calf serum (FCS; Gibco 
Lab., New York, USA), 100 IU/ml penicillin, 10/µg/
ml neomycin and 10 µg/ml streptomycin (Polfa, 
Tarchomin, Poland) in a humidified atmosphere 
with 5% CO2 at 37oC.
Transfection procedure. DU145 cells were 
seeded one day before transfection at density 
0.08 × 106 per well of 24-well plate in DMEM-F12 
with 10% FCS but without antibiotics and grown 
to 70–80% confluency. Heptaprenyltrimethylammo-
nium salt and helper lipid dioleylphosphatidyleth-
anolamine (DOPE) were diluted in 99% ethanol to 
achieve final concentrations of 10 mg/ml and 3.2 mg/
ml, respectively. Next, they were diluted and vor-
texed to suspend the lipid in DMEM-F12 medium 
without serum, at the indicated heptaprenyltrimethyl-
ammonium iodide/DOPE ratio (w/w). The plasmid 
pEGFP-C1 (kindly supplied by Professor A. F. Sikor-
ski, University of Wrocław, Poland) was dissolved in 
DMEM-F12 without serum to a final concentration 
of 0.01 µg /µl. Equal volumes of cationic liposome 
suspension (the final lipid concentration indicated in 
the text) and plasmid DNA were gently mixed and 
incubated for 30 min at room temperature and then 
diluted 4 times with DMEM-F12 without serum. 
Medium from cells was aspirated and replaced with 
200 µl of DMEM-F12 without serum and 200 µl of 
diluted complexes (transfection mixture). Cells were 
incubated at 37oC in 5% CO2 for 5 h. Then 400 µl 
DMEM-F12 containing 2 × the normal concentration 
of serum and antibiotics was added without remov-
ing the transfection mixture. The transfection effi-
ciency was calculated after 24 h. Cells were washed 
with PBS and incubated in the presence of Hoechst 
33342 (Sigma, St. Louis, MO, USA) (1 µg/ml in PBS) 
for 10 min. After this time cells were again washed 
with PBS and growing medium was added. The 
proportion of transfected cells was calculated under 
fluorescence Leica DM IRE2 microscope equipped 
with Leica DC350 FX digital camera as follows: 
(Number of cells expressing GFP/Number of cells 
stained with Hoechst 33342) × 100%.
Lipofectamine 2000 reagent was used as a pos-
itive control. Diluted plasmid was combined with di-
luted lipofectamine 2000 (1 µl of lipofectamine : 0.25 
µg of plasmid) total volume (50 µl ) and incubated 
for 30 min at room temp. Then, the diluted com-
plexes were used for the transfection procedure as 
described above.
Figure 1. Structures of heptaprenyltrimethylammonium 
(A) and nonaprenyltrimethylammonium (B) iodides.
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RESULTS 
Transfection efficiency on using heptaprenyltrimeth-
ylammonium salt
Transfection efficiency of this polyprenyl de-
rivative was estimated by means of GFP-expression 
assay (Fig. 2). Cationic liposomes were prepared 
by mixing heptaprenyltrimethylammonium iodide 
and dioleyl phosphatidylethanolamine in ratio 3 : 1, 
followed by mixing with a plasmid DNA, pEGFP-
C1, which encodes green fluorescent protein (GFP). 
DU145 cells were transfected with the liposome-
DNA complex and the transfection efficiency was 
evaluated by means of fluorescence microscopy. As 
shown in Fig. 2, heptaprenyltrimethylammonium 
salt containing liposomes induced efficient transfec-
tion of DU145 cells. The highest transfection efficien-
cy (32% of transfected cells) was observed at 1 µg of 
lipids per well (Fig. 3).
Interestingly, another tested compound – non-
aprenyltrimethylammonium iodide under the same 
experimental procedure induced transfection with 
low efficiency, not exceeding 5% (not shown). This 
result seems to be consistent with previous obser-
vations that shorter-chain lipids are more fusogenic 
than long-chain ones (Tarahovsky et al., 2004). Cati-
onic lipids are usually formulated as liposomes us-
ing co-lipids such as DOPE (Rao & Gopal, 2006). In 
our preliminary research we prepared cationic lipo-
somes by mixing heptaprenyltrimethylammonium 
salt with DOPE in ratio 3 : 1 (Fig. 3). However, trans-
fection efficiency of such liposomes was lower than 
with commercially available lipofectamine 2000, used 
in our experiments as a positive control (Fig. 3). To 
improve efficiency of transfection we investigated the 
effect of liposomes prepared in various heptaprenylt-
rimethylammonium salt and DOPE ratios. The results 
presented in Fig. 4 show that optimal efficiency (ex-
ceeding 40%) was obtained for the lipids in a ratio of 
1 : 1. This is comparable to other highly efficient lipo-
fectamines, e.g., lipofectamine 2000 (Fig. 4).
DISCUSSION
The data presented in this report extend the list 
of cationic lipids that may be used as components of 
lipofecting mixtures. The idea of constructing cationic 
lipids built from linear isoprene polymers came from 
the already known information on the effect of poly-
prenols and dolichols on artificial lipid membranes 
Figure 2. Transfection of DU145 cells in vitro with heptaprenyltrimethylammonium salt pEGFP–C1 complexes and 
lipofectamine 2000-pEGFP-C1 complexes.
(A,B) DU145 cells treated with heptaprenyltrimethylammnium salt contaning pEGFP-C1 complexes or Lipofectamine 
2000–pEGFP-C1 complexes (C, D). (A, C) Nomarski Interference contrast. (B, D) Epifluorescence microscopy with FITC 
filter. Scale bar 100 µm.
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(Valtersson et al., 1985; Janas et al., 1986). It was also 
known that the phosphate derivatives of these com-
pounds function as lipid coenzymes of transglycosyla-
tion in the cell and may play an important role in nat-
ural cellular membranes (Chojnacki & Dallner, 1988).
The cationic forms of linear polymers of iso-
prene units do not occur in living organisms. Data 
are reported concerning the synthesis of such sub-
stances from naturally occurring plant isoprenoid al-
cohols, heptaprenol of the wood of Betula verrucosa 
(Lindgren, 1965) and other members of Betulaceae 
(Chojnacki, unpublished) and nonaprenol from 
leaves of Nicotiana tabacum (Rowland, 1955) and 
from several other plants. Several linear poly-cis-pre-
nols occur in many plants as secondary metabolites 
(e.g.: Stone et al., 1967; Swiezewska et al., 1994). 
The lack of the lipofecting activity of nonapre-
nyltrimethylammonium salt observed in the present 
study may be due not only to the length of the iso-
prenoid chain of nonaprenyl radical as postulated by 
Tarahovsky et al. (2004) but also to the stiff, all-trans 
structure of this unit. The current studies of our labo-
ratories on derivatizing several linear cationic polypre-
noids available in the Collection of Polyprenols of the 
Institute of Biochemistry and Biophysics, PAS, (Mas-
nyk et al., in preparation) should solve this question. 
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Figure 3. Transfection efficiency of various concentration 
of heptaprenyltrimethylammonium salt in lipofecting 
mixture. 
Transfection activities of cationic liposomes prepared with 
heptaprenyltrimethylammonium iodide and DOPE (ratio 
3 : 1) were expressed as percentage of cells emitting green 
fluorescence. Each value represents the mean ± S.D. (n = 4).
Figure 4. The effect of heptaprenyltrimethylammonium 
iodide : DOPE ratio on transfection efficiency.
Transfection activities of cationic liposomes prepared with 
heptaprenyltrimethylammonium iodide and DOPE (final 
lipid concentration 1 µg/well) at various ratios were ex-
pressed as percentage of cells emitting green fluorescence. 
Each value represents the mean ± S.D. (n = 4).
